Latest Innovation News

Renascor Resources has completed key preparatory milestones for its Purified Spherical Graphite demonstration plant in Adelaide, with construction set to begin next month. The facility aims to challenge China’s dominance in battery anode materials using an innovative, eco-friendly purification process.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

GDI Property Group has reported a strong turnaround in FY25, posting a $35.6 million net profit and a 20% increase in Funds From Operations, while maintaining its distribution at 5 cents per security.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Michael Hill International reported steady FY25 results with flat revenue and modest profit improvement amid challenging market conditions. The company is focusing on brand repositioning, operational efficiency, and AI innovation as it navigates a complex retail environment.

Michael Hill International reported broadly flat FY25 financial results despite challenging retail conditions, with growth in Australia and Canada offset by ongoing difficulties in New Zealand. Strategic initiatives and early FY26 sales hint at cautious optimism.

Rubicon Water’s FY25 results reveal strong global revenue growth led by the US and EMEA, alongside a narrowing EBITDA loss despite operational headwinds and strategic restructuring in China.

Michael Hill International reported a steady FY25 with revenue holding firm at $643.7 million and a return to profitability despite ongoing retail challenges. The year saw strategic store closures, digital sales growth, and leadership changes, setting the stage for a reset under new CEO Jonathan Waecker.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

DATA#3 Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending June 2025, signaling steady shareholder returns amid a stable financial period.

Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.